• CAR T-cell Therapy in Australia: Paradigm Changing Technology

  • May 28 2024
  • Length: 33 mins
  • Podcast

CAR T-cell Therapy in Australia: Paradigm Changing Technology

  • Summary

  • In this PCPA Podcast Dr Ian Irving, PCPA Board Member, Haematologist and Chief Medical Officer at ICON Group, discusses CAR T-cell therapy, a transformative approach reshaping the landscape of haematologic malignancies. CAR T-cell therapy leverages a patient's own immune system to target and eradicate cancer cells with remarkable precision. Throughout this episode, we delve into the mechanisms of action, clinical trial data, and practical considerations for integrating CAR T-cell therapy into your practice. Ian is joined by Associate Professor Mary Ann Anderson, Haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, Haematologist from the Fiona Stanley Hospital in Perth.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about CAR T-cell Therapy in Australia: Paradigm Changing Technology

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.